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Synthetic peptide 1142-I 153 of the insulin receptor was phosphorylated on tyrosine by the insulin receptor and found 
to be a potent substrate for dephosphorylation by rat liver particulate and soluble phosphotyrosyl protein phosphatases. 
Apparent K,,, values were N 5 PM. V,,, values (nmol phosphate removed/mm per mg protein) were 0.62 (particulate) and 
0.2 (soluble). This corresponds to 80% of total activity being membrane-associated, indicating that membrane-bound 
phosphatases are important receptor phosphatases. The phosphatase activities were distinct from acid and alkaline phos- 
phatase. In conclusion peptide 1142-l 153 provides a useful tool for the further study and characterization of phospho- 
tyrosyl protein phosphatases. 
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1. INTRODUCTION 
The insulin receptor is an insulin-activated, 
tyrosine-specific protein kinase which catalyzes the 
autophosphorylation of tyrosine residues in its own 
&subunit [l-3]. Autophosphorylation activates the 
tyrosine kinase to phosphorylate other proteins 
[4,5]. This activated state is maintained even after 
dissociation of bound insulin and consequently de- 
phosphorylation is required to terminate tyrosine 
kinase activity. Thus, the phosphotyrosyl protein 
phosphatase(s) which catalyzes dephosphorylation 
of the insulin receptor plays an important function 
in terminating the insulin signal and in the overall 
scheme of insulin action. 
Study of phosphotyrosyl protein phosphatase(s) 
with activity against the insulin receptor has been 
hampered by the low amounts of receptor routinely 
available and the lack of a suitable alternate 
specific substrate. Studies in other systems on 
Correspondence address: G.J. Sale, Department of Bio- 
chemistry, School of Biochemical and Physiological Sciences, 
University of Southampton, Bassett Crescent East, Southamp- 
ton SO9 3TU, England 
phosphotyrosyl protein phosphatases have utilized 
artificial substrates like casein or bovine serum 
albumin that have been phosphorylated on tyrosine 
[6-131. However, phosphotyrosine in these sub- 
strates may not be present within protein sequences 
representative of the insulin receptor raising the 
possibility that phosphatases with the highest ac- 
tivity and specificity towards the insulin receptor 
may be missed. Most ideal would be to use as sub- 
strate a synthetic peptide corresponding to the 
phosphorylation sites of the insulin receptor. How- 
ever, a previous study showed that a phospho- 
tyrosyl peptide derived from pp60”‘” was not de- 
phosphorylated by two species of cytosolic phos- 
photyrosyl protein phosphatase and it was con- 
cluded that more extensive tertiary structure than 
afforded by short peptides was required for 
recognition by phosphotyrosyl protein phos- 
phatase [ 141. 
In the present work we show that peptide 
1142-l 153 of the insulin receptor which contains 
three of the tyrosine residues autophosphorylated 
in the insulin receptor (Tyr 1146, 1150, 1151) is 
after phosphorylation a highly effective substrate 
for phosphotyrosyl protein phosphatase. The use 
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of phosphotyrosyl peptide in phosphatase assays 
and properties of rat liver particulate and soluble 
phosphatase activity against the phosphotyrosyl 
peptide are described. 
2. MATERIALS AND METHODS 
Sources of materials and methods were as described in [16,17] 
except where detailed below. 
2.1. Preparation of 3zP-labelled peptide 1142-1153 
Peptide 1142-1153, N-Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp- 
Tyr-Tyr-Arg-Lys-C, corresponding to amino acids 1142-l 153 in 
the precursor of the human insulin receptor, was synthesized 
manually using a solid-phase method in collaboration with Dr 
R. Sharma of this department. The peptide (200 PM) was mono- 
phosphorylated as described in [15] by incubation for 90 min at 
22°C with human placental insulin receptor [16], 150 nM in- 
sulin, 2OOpM [y-32P]ATP (2-4 cpm/fmol), 2 mM MnClz, 
10 mM MgCls, 0.3 M NaCl in 30 mM Hepes (pH 7.4)/0.07% 
Triton X-100. Under these conditions approx. 90% of 32P incor- 
porated into the peptide was located at Tyr 1150 and the 
stoichiometry of phosphorylation was approx. 0.1 mol/mol 
peptide. 32P-peptide 1142-1153 was separated from non- 
peptide-bound 32P by chromatography on AC l-X2 acetate 
(Bio-Rad) columns [14] using 1 M acetic acid and lyophilized. 
2.2. Dephosphorylation assay 
Particulate and soluble fractions were prepared from a rat 
liver homogenate by centrifugation at 100000 x g for 1 h as in 
[17]. “P-peptide 1142-l 153 at the concentrations indicated was 
incubated at 30°C in 50 mM Hepes (pH 7.4)/0.2 mM dithio- 
threitol with particulate or soluble extract (0.25-l mg/ml) in a 
final volume of 30-100~1. Other additions of metal ions, 
EDTA, calmodulin or sodium vanadate were present where in- 
dicated. Loss of “Pi from the peptide was measured by mixing 
aliquots of the reaction mixture with an equal volume of 10% 
(w/v) trichloroacetic acid, centrifuging 10000 x g, 5 min) and 
spotting 15-~1 aliquots of the supernatant onto l-cm squares of 
Whatman P81 phosphocellulose paper [18]. The papers were 
washed in 0.42 mM acetic acid (pH 3.5) at 70-75°C for 4 min 
and rinsed in distilled water. 32P-peptide 1142-l 153 bound to 
the papers was measured by placing the papers in 5 ml scintilla- 
tion fluid (5-(4-biphenylyl)-2-(4-t-butylphenyl)-l-oxa-3,4-di- 
azole (6 g/l) in toluene] and counting. Alternatively, “Pi re- 
leased from “‘P-peptide 1142-l 153 was measured using a pro- 
cedure [19] which measured “P-1abelled Pi as opposed to 
peptide-bound 32P. With this method, incubations were ter- 
minated by adding 3 vols of 10% (w/v) trichloroacetic acid and 
centrifuging (10000 x g, 5 min). A 70 ~1 aliquot of the superna- 
tant was mized with 0.14 ml of 1.25 mM KHtP04 in 1.0 N 
HsS04 and 0.35 ml isobutanol/benzene (1: 1) was added. The 
solutions were mixed and 70~1 of 5% ammonium molybdate 
was added. After further mixing the organic and aqueous phases 
were allowed to separate and 0.1 ml of the organic phase 
counted. The procedure was performed at 0-4°C. Both methods 
gave similar results. Reaction rates were linear up to 15% 
phosphate released from the peptide, and the extent of 
dephosphorylation was therefore kept within this limit in quan- 
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titative assays. Concentrations of phosphotyrosyl peptide were 
calculated from 32P content and specific activity of [Y-‘~P]ATP. 
3. RESULTS AND DISCUSSION 
The ability of phosphotyrosyl protein phos- 
phatase(s) to dephosphorylate [32P]phosphotyrosyl 
peptide 1142-I 153 was studied using rat liver par- 
ticulate and soluble fractions. Recently, we have 
shown that both these subcellular fractions contain 
a high activity of phosphatase towards phospho- 
tyrosyl insulin receptor [ 171. Additionally, proper- 
ties of the phosphatase activities against phospho- 
tyrosyl insulin recpetor were characterized. Thus, 
rat liver particulate and soluble fractions provide 
an excellent source of phosphatase activity for 
analysing the viability of 32P-peptide 1142-l 153 as 
a suitable substrate. 
Fig.1 shows that ‘*P-peptide 1142-1153 was de- 
phosphorylated rapidly by both particulate and 
soluble fractions from rat liver. For comparison, 
dephosphorylation of the peptide by calmodulin- 
dependent protein phosphatase (also called protein 
phosphatase 2B or calcineurin), an enzyme 
reported to dephosphorylate tyrosyl residues in 
autophosphorylated epidermal growth factor 
receptor and other proteins [20,21] was assessed. 
32P-peptide 1142-1153 was a poor substrate for 
calmodulin-dependent protein phosphatase ven at 
high concentrations of the phosphatase (0.1 mg/ 
ml). This observation supports the idea that cal- 
modulin-dependent protein phosphatase is not a 
major phosphotyrosyl insulin receptor phosphat- 
ase [ 171. Plots of initial rates of 32P removal from 
the peptide vs amount of phosphatase activity 
added were linear (not shown). 
The properties of phosphotyrosyl protein phos- 
phatase activity against 32P-peptide 1142-l 153 
were examined (table 1). Both particulate and solu- 
ble phosphatase activities were inhibited > 90% by 
Zn2+ (5OOpM) or vanadate (20pM) but were not 
inhibited by EDTA (1 mM). Activity in the 
presence of EDTA [22] and inhibition by vanadate 
[23-251 show that these phosphotyrosyl protein 
phosphatases are distinct from alkaline phos- 
phatase and acid phosphatase. Mn2+, Ca2+ and 
Mg2+ at 1 mM did not profoundly alter phos- 
phatase activity. Ni2+ (1 mM) inhibited phos- 
phatase activity 76-52%. These characteristics of 
rat liver particulate and soluble phosphotyrosyl 
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Fig. 1. Time courses for dephosphorylation of “P-peptide 
1142-l 153. Incubations contained phosphotyrosyl peptide 
(1 FM) and 1 .O mg/ml of rat liver particulate (0) fraction, solu- 
ble fraction (0) or 0.1 mg/ml of purified bovine brain 
calmodulin-dependent protein phosphatase (m). At the in- 
dicated times peptide-bound “P was measured using the phos- 
phocellulose paper square method. Calmodulin-dependent pro- 
tein phosphatase was activated by preincubation at 30°C for 
20 min with 1 mM Mnzf/l mM CaZC/l PM calmodulin prior to 
use. The same mixture of metal ions and calmodulin was present 
in the incubations with calmodulin-dependent protein phos- 
phatase. Incubations with rat liver fractions contained 0.8 mM 
EDTA. 
protein phosphatase activity against 32P-peptide 
1142-1153 parallel those found using autophos- 
phorylated insulin receptor in 0.1% Triton X-100 
as substrate [171. 
Apparent K,,, values of particulate and soluble 
phosphatase activity for 32P-peptide 1142-l 153 
were not significantly different (5.4 + 0.8 and 
4.8 + 0.6 PM, respectively; means * SE, 3 obser- 
Table 1 
Effect of various agents on rat liver particulate and soluble 
phosphatase activity against “P-peptide 1142-l 153 
Conditions pmol 32Pi released/min per mg 
Soluble Particulate 
Control 71.3 208 
Mg2+ (1 mM) 92.2 225 
Ca2+ (1 mM) 87.0 230 
Mn’+ (1 mM) 68.6 204 
Ni2+ (1 mM) 22.0 111 
NarV04 (20 PM) 0.0 23 
Zn2+ (500 PM) 0.6 11 
EDTA (1 mM) 67.5 176 
Phosphotyrosyl peptide (2.5 PM) was incubated with 
0.25 mg/ml of particulate or soluble fraction in the presence of 
the indicated additions for 5 min. “Pi released from the peptide 
was determined by the molybdate method 
Fig.2. Lineweaver-Burk plot for dephosphorylation of “P- 
peptide 1142-1153 by rat liver particulate (0) and soluble phos- 
phatases (0). Various concentrations of phosphotyrosyl pep- 
tide (0.3-2.8~M) were incubated with 0.25 mg/ml of par- 
ticulate or soluble fraction in the presence of 0.5 mM EDTA. 
After 1,2, 5 and 10 min of incubation aliquots were assayed for 
‘2Pi released using the molybdate method and initial rates of “Pi 
release calculated. 
vations; fig.2). In Lineweaver-Burk plots there was 
no evidence of curvature, indicating the absence of 
phosphatases of markedly differing affinities in 
either fraction. Additionally, it is noteworthy that 
several species of phosphotyrosyl protein phos- 
phatase resolved from both particulate and soluble 
phases of human placenta all had identical Km 
values for phosphotyrosyl lysozyme [ 131. Vi,, values 
of particulate and soluble phosphatase activity 
towards 32P-peptide 1142-l 153 were 0.62 f 0.13 
and 0.2 f 0.05 nmol 32P removed/min per mg pro- 
tein, respectively (means f SE, 3 observations). 
After correcting for yields of particulate and solu- 
ble fractions this corresponds to 80 + 5% (means 
+ SE, 3 observations) of phosphatase activity be- 
ing membrane-associated. This proportion is 
similar to that measured irectly using either auto- 
phosphorylated insulin or EGF receptor as sub- 
strate [17], but significantly higher than that 
reported in other studies which have utilized ar- 
tificial substrates like phosphotyrosyl bovine serum 
albumin [ 11,261. 
In conclusion, phosphotyrosyl peptide 1142- 
1 153 has been shown to be an efficient substrate for 
dephosphorylation by phosphotyrosyl protein 
phosphatase(s). Thus, extensive tertiary structure is 
not a prerequisite for interaction of all 
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phosphotyrosyl protein phosphatases with their 
substrates. Properties of rat liver phosphatases ac- 
tive against the peptide paralleled those active 
against autophosphorylated insulin receptor. Thus, 
phosphotyrosyl peptide 1142-l 153 is an excellent 
substrate for the further study and characterization 
of phosphotyrosyl protein phosphatases. The 
phosphatases exhibited high affinities for the pep- 
tide. This may be of significance in facilitating de- 
phosphorylation of receptors present at low con- 
centrations in cells. Potent phosphatase activity 
against phosphotyrosyl peptide 1142-l 153 was 
found in both cytosolic and membrane fractions of 
rat liver with the majority (80%) in the latter. This 
places the phosphatase in the correct location to in- 
teract with the insulin receptor. 
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